Go to deals
TMT | Private Equity

Eterus Capital has acquired a minority stake in HOPIN

Eterus Capital has acquired a 40% stake in HOPIN. Financial details have not been disclosed.

Eterus Capital is a Slovak private equity fund which has been helping Slovak companies grow since 2008.

HOPIN is a developer of a ride-hailing application. It was released in 2012 as the most popular taxi app in Slovakia. The app allows users to order taxis and luxury limousines without a dispatch call, track public transport vehicles in real time and check relevant timetables.

Oaklins' team in Slovakia provided transaction and valuation services in this acquisition.

Parties

Talk to the deal team

Jozef Streženec

Senior Manager
Bratislava, Slovakia
Oaklins WOOD & Co.

Boris Kostik

Associate Partner
Bratislava, Slovakia
Oaklins WOOD & Co.

Related deals

Den Berk Délice accelerates growth through strategic partnership
Private Equity | Agriculture

Den Berk Délice accelerates growth through strategic partnership

Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.

Learn more
Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida
Private Equity | Financial Services

Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida

Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.

Learn more
Bayer AG has entered into a takeover agreement with Cara Care
Healthcare | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Learn more